Upload Avatar (500 x 500)
Jiwu Wei
Medical School
Nanjing University
Jiangsu
Language: Chinese, German
Oncolytic Virus
Immunotherapy
Recombinant Virus
Tumor Inflammation
Metabolic Microenvironment
Biotherapy
Cancer Treatment
Adenovirus
Poxvirus
Rna Therapy
Areas of Focus
- Recombinant oncolytic virus-mediated oncolytic immunotherapy
- Biotherapy regulating tumor inflammation and metabolic microenvironment
Work Experience
- 1993-2001 - Attending Physician, Neurosurgery, Third Affiliated Hospital of Jinan University Medical School
- 2001-2003 - PhD Student, Ulm University Medical School, Germany
- 2003-2006 - Postdoctoral Researcher, Ulm University Medical School, Germany
- 2007-2009 - Postdoctoral Researcher, Munich University Medical School, Germany
- 2009-present - Professor and Doctoral Supervisor, Nanjing University Medical School
Academic Background & Achievements
- 1993 - Graduated from Huazhong University of Science and Technology, Clinical Medicine (German class)
- 2001 - Master's in Pathology from Jinan University Medical School
- 2003 - PhD from Ulm University Medical School, Germany
- 2006 - Postdoctoral Researcher at Ulm University Medical School, Germany
- 2009 - Postdoctoral Researcher at Munich University Medical School, Germany
- Published research in top journals like Cancer Cell, Cancer Res., Int J Cancer, JVI, Nature Comm., Mol Ther., and BJC
- Granted 3 invention patents and applied for 10 national invention patents
- Led 4 national and 2 provincial research projects
Publications
- Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma, Zuo S, Wei M, Wang S, Dong J, Wei J, 2020
- Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma, Meng G, Li B, Chen A, Zheng M, Xu T, Zhang H, Dong J, Wu J, Yu D, Wei J, 2020
- Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy, Xia M, Luo D, Dong J, Zheng M, Meng G, Wu J, Wei J, 2019
- Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8+ T Cells in HCC, Zhang Y, Zhang H, Wei M, Mou T, Shi T, Ma Y, Cai X, Li Y, Dong J, Wei J, 2019
- A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer, Zuo S, Wei M, Zhang H, Chen A, Wu J, Wei J, Dong J, 2019
- Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma, Meng G, Fei Z, Fang M, Li B, Chen A, Xu C, Xia M, Yu D, Wei J, 2019
- CD8+ T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma, Xu C, Lu X, Liu W, Chen A, Meng G, Zhang H, Li B, Zhang Y, Wu J, Wei J, 2018
- Carrier Cells for Delivery of Oncolytic Measles Virus into Tumors: Determinants of Efficient Loading, Xu C, Xia M, Meng G, Li C, Jiang A, Wei J, 2018
- The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma, Lu X, Wo G, Li B, Xu C, Wu J, Jiang C, Wei J
- NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate Slug expression, Ju J, Chen A, Deng Y, Liu M, Wang Y, Wang Y, Nie M, Wang C, Ding H, Yao B, Gui T, Li X, Xu Z, Ma C, Song Y, Kvansakul M, Zen K, Zhang CY, Luo C, Fang M, Huang DCS, Allis CD, Tan R, Zeng CK, Wei J, Zhao Q, 2017
- Oncolytic measles virus enhances antitumour responses of adoptive CD8+NKG2D+ cells in hepatocellular carcinoma treatment, Chen A, Zhang Y, Meng G, Jiang D, Zhang H, Zheng M, Xia M, Jiang A, Wu J, Beltinger C, Wei J, 2017
Awards
- 2018 - Nanjing University 'My Favorite Teacher'
- 2019 - Nanjing University 'Charismatic Mentor'
